Topic: subscription models health screening

Sort by: Relevance | Date
  • Craif Secures $22M to Advance Early Cancer Detection Tech
    April 28, 2025
    55%

    Craif Secures $22M to Advance Early Cancer Detection Tech

    Craif, a Japanese biotech startup, secured $22 million in Series C funding to expand its urine-based cancer detection technology into the U.S. market, addressing the limitations of current invasive screening methods. The company’s miSignal platform, utilizing microRNA biomarkers in urine, has alr...

    Read More »

Related Topics

non-invasive screening methods (1) craifs product misignal (1) early cancer detection (1) neurodegenerative disease applications (1) craifs series c funding (1) urine-based testing technology (1) expansion into us market (1) cancer statistics (1)
Close

Adblock Detected

We noticed you're using an ad blocker. To continue enjoying our content and support our work, please consider disabling your ad blocker for this site. Ads help keep our content free and accessible. Thank you for your understanding!